ERBB2 and neoplasm: In murine models of glioblastoma, the use of adeno-associated virus (AAV) vectors encoding checkpoint inhibitors in combination with HER2-targeted CAR-NK cells enhanced tumor clearance and promoted local inflammation within the tumor microenvironment [26].